Table 3b.
Multivariate logistic regression analysis for predictors to positive IgG antibodies following the second dose of vaccine in immunocompromised patients (846), patients with HIV (156) and immunocompetent controls (272); N = 1274.
| Effect | Odds ratio | Lower 95% CI | Upper 95% CI | P-value |
|---|---|---|---|---|
| Age, > 65 yr vs. < 65yr | 0.54 | 0.41 | 0.72 | < 0.0001 |
| Gender, F vs. M | 1.34 | 1.00 | 1.79 | 0.04 |
| Days after 2nd vaccine | 1.38 | 1.03 | 1.84 | 0.031 |
| HIV vs. controls | 0.90 | 0.15 | 5.53 | 0.91 |
| All ICP except HIV vs. controls | 0.02 | 0.01 | 0.07 | < 0.001 |
CI – confidence interval. F - female, M- male, HSCT - hematopoietic stem cell transplantation, CLL - chronic lymphocytic leukemia, NHL - non-Hodgkin's lymphoma, HIV - human immunodeficiency virus.